Ken Fisher’s Medifast MED Stock Holding History

Ken Fisher’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-220	Closed	-$16.5K	–	1069
2023 Q3	$16.5K	Buy	220 +129	+142%	+$11.4K	﹤0.01%	1081
2023 Q2	$8.39K	Hold	91	–	–	﹤0.01%	1105
2023 Q1	$9.58K	Buy	+91	New	+$10.1K	﹤0.01%	1058

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ken Fisher's MED Position: Q4 2023 in Review

Ken Fisher sold out of Medifast (MED) in Q4 2023, closing a stake of 220 shares — an estimated $16.5K sold.

Ken Fisher first reported a position in MED in Q1 2023 and held it in 3 quarters. The position peaked at $16.5K in Q3 2023. 216 funds tracked by Wall St. Rank hold MED as of Q4 2023.

Ken Fisher reported no remaining Medifast position as of Q4 2023 after selling out during the quarter.
Ken Fisher sold 220 Medifast shares in Q4 2023, an estimated $16.5K.
Ken Fisher first reported a position in Medifast in Q1 2023 and held it in 3 quarters.
Ken Fisher's Medifast position peaked at $16.5K in Q3 2023.
216 funds tracked by Wall St. Rank held Medifast as of Q4 2023.

Based on Fisher Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.